For what concerns our urologic practice, we dismissed the frontal medical examination for follow-up of most prostate cancer patients previously cured with active treatment (i.e., radical prostatectomy or radiotherapy) and implemented phone interviews to collect prostate-specific antigen (PSA) values or patient symptoms. The gene discussed is KLK3; the disease is prostate cancer.